Sign inGet started

Link David Charles

Insider CIK 1889464 · SABS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SABS SAB Biotherapeutics, Inc. A Award deriv2024-07-152024-07-1720,000— $020,000SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2024-07-152024-07-179,305— $09,305SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2022-12-072022-12-0941,493— $041,493SEC↗
SABS SAB Biotherapeutics, Inc. A Award2022-12-072022-12-0941,493$1.21 $50.2K57,313SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-2669,793— $069,793SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-266,391— $06,391SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-264,887— $04,887SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-2617,231— $017,231SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2021-10-222021-10-2623,264— $023,264SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-10-222021-10-2612,097— $012,097SEC↗
SABS SAB Biotherapeutics, Inc. A Award2021-10-222021-10-2615,820— $015,820SEC↗